Showing results (81-90 of 148) with videos related to
Sort By:
Pageof 15
Substance Use & Misuse|March 22, 2017
The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across SubtypesNavneet Upadhyay, Hua Chen, Osaro Mgbere, et al.International Journal of Geriatric Psychiatry|November 10, 2020
Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladderNandita Kachru, Holly M Holmes, Michael L Johnson, et al.Pharmacotherapy|September 17, 2024
Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare dataAshna Talwar, Satabdi Chatterjee, Susan Abughosh, et al.Research in Social & Administrative Pharmacy : RSAP|March 16, 2020
Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national dataJagadeswara R Earla, Rutugandha Paranjpe, Nandita Kachru, et al.Current Medical Research and Opinion|April 23, 2021
Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries studyNandita Kachru, Holly M Holmes, Michael L Johnson, et al.Exploratory Research in Clinical and Social Pharmacy|September 4, 2023
Performance of advanced machine learning algorithms overlogistic regression in predicting hospital readmissions: A meta-analysisAshna Talwar, Maria A Lopez-Olivo, Yinan Huang, et al.Journal of General Internal Medicine|February 7, 2020
Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective StudyNandita Kachru, Holly M Holmes, Michael L Johnson, et al.Drugs & Aging|March 12, 2024
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase InhibitorsAshna Talwar, Satabdi Chatterjee, Jeffrey Sherer, et al.Multiple Sclerosis and Related Disorders|March 12, 2022
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSISJieni Li, Soumya G Chikermane, Jagadeswara R Earla, et al.Multiple Sclerosis and Related Disorders|April 4, 2024
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosisJagadeswara Rao Earla, Jieni Li, George J Hutton, et al.Pageof 15